Maia BiotechnologyMAIA
13F holders, Q1 2024 (March 31)20holders
2famous investors
$2.27avg. 13F price*
At the end of Q1 2024, 20 institutions reported holding Maia Biotechnology Inc. (MAIA) in their 13F filings. The largest holders were Vanguard Group Inc. ($620K), Centric Wealth Management ($197K) and Geode Capital Management, LLC ($117K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Maia Biotechnology Inc.
- CUSIP
- 552641102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $126K |
| Exits | 5 | $197K |
Ownership 20 holders
| Vanguard Group Inc. | 0.00% | Add +61.7% | 281,682 | $620K |
| Centric Wealth Management | 0.06% | No change | 67,198 | $197K |
| Geode Capital Management, LLC | 0.00% | Add +19.5% | 53,257 | $117K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -39.6% | 45,700 | $101K |
| Virtu Financial LLC | 0.01% | New | 32,487 | $71K |
| Jane Street Group, LLC | 0.00% | New | 25,065 | $55K |
| Citadel Advisors | 0.00% | Reduce -58.7% | 23,749 | $52K |
| Naviter Wealth, LLC | 0.01% | No change | 22,168 | $49K |
| State Street Corp. | 0.00% | No change | 21,300 | $47K |
| Northern Trust Corp. | 0.00% | No change | 20,273 | $45K |
| Renaissance Technologies | 0.00% | Reduce -82.9% | 19,000 | $42K |
| BlackRock Inc. | 0.00% | Reduce -1.3% | 16,992 | $37K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Add +8.1% | 16,000 | $35K |
| Morgan Stanley | 0.00% | Add +98.1% | 10,095 | $22K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +57.6% | 5,665 | $12K |
| Sunbelt Securities, Inc. | 0.00% | Reduce -33.3% | 100 | $220 |
| Wells Fargo & Company | 0.00% | Add +31.9% | 91 | $200 |
| JPMorgan Chase & Co. | 0.00% | Reduce -51.3% | 38 | $84 |
| Mather Group, Llc. | 0.00% | New | 24 | $28 |
| Royal Bank of Canada | 0.00% | Reduce -81.1% | 28 | $0 |
"% of holder's portfolio" is MAIA's weight in each manager's 13F, not the share of Maia Biotechnology Inc. the manager owns.